October 27-29, 2010 • Grand Hyatt Hotel • San Francisco, CA
Download the latest event brochure here
Nearly 30 innovators/start-ups scheduled to present – A few spaces are still available!
22+ investors and key industry leaders scheduled to present, including Medtronic, the FDA, Alcon Labs, and more.
Don’t miss these important sessions:
- What Are Corporate Buyers Looking For? 1) Current philosophy/approach to investing, 2) The role of M&A, 3) Hot technology/therapeutic areas, 4) How start-ups can get corporate attention, 5) Recent M&A case studies.
- Patent Strategies for Medical Device Companies – Case Studies 2010.
- Medical Device Investing, Financing and Exit Strategies: The Hot Deals Now and in the Future.
- Changes to the 510(k) Program – New Requirements You Must Implement: 1) Specific reforms being put into place now and what’s ahead, 2) Strategies for responding to the changes, 3) Why FDA says not to panic.
Contact Kayleen Kell for specific details and/or speaking opportunities at k.kell@elsevier.com or +1-949-453-0071.